STRENGTHING CLINICAL TRIALS FOR CANADIANS
RENFORCEMENT DES ESSAIS CLINIQUES POUR LES CANADIENS
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
Archive for: 2018 Exec. Committee
May 7, 2018
May 7, 2018
May 7, 2018
Read More
April 17, 2018
April 17, 2018
April 17, 2018
Read More
March 14, 2018
March 14, 2018
March 14, 2018
Read More
January 29, 2018
January 29th, 2018 – In Person
January 29, 2018
Read More
About
Executive Committee
Initiatives
Canadian Clinical Trials Asset Map (CCTAM)
model Clinical Trials Agreement (mCTA)
Provincial Clinical Trials Organisations’ Meetings
Investment Case – “Clinical Trials -the Canadian Advantage”
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Clinical Trials Metrics Platform
Reports
2018 Strategic Planning Report: A Pan-Canadian Clinical Trial Strategy
The CCTCC 2014-2017 Report to Stakeholders
Investment Case – “Clinical Trials -the Canadian Advantage”
News
Contact
